Hypera S.A. ( HYPMY) - Key Metrics
HYPMY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.32 | $0.70 | $1.16 | $0.98 |
| 2026Q1 | $3.12 | $0.54 | $0.31 | $0.19 |
| 2025Q4 | $3.50 | $0.71 | $1.11 | $0.81 |
| 2025Q3 | $3.52 | $0.72 | $1.08 | $0.90 |
| 2025Q2 | $3.41 | $0.68 | $0.70 | $0.34 |
HYPMY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 5.60% | 7.38 |
| 2026Q1 | 34.49% | 10.24 |
| 2025Q4 | 128.35% | 7.98 |
| 2025Q3 | 5.31% | 7.72 |
| 2025Q2 | 5.78% | 9.64 |
HYPMY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 4.60% | 0.18% |
| 2026Q1 | 0.84% | 0.82% |
| 2025Q4 | 3.58% | 3.99% |
| 2025Q3 | 4.07% | 0.17% |
| 2025Q2 | 1.31% | 0.15% |
HYPMY
Price: $4.30
Dividend Yield: 5.09%
Forward Dividend Yield: 2.97%
Payout Ratio: 30.43%
Dividend Per Share: 0.13 USD
Earnings Per Share: 0.52 USD
P/E Ratio: 7.92
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Brazil
Market Capitalization: 2.9 billion
Average Dividend Frequency: 5
Years Paying Dividends: 11
DGR3: -0.63%
DGR5: -2.23%